[go: up one dir, main page]

GB201005521D0 - Stabilised liquid formulations of virus particles - Google Patents

Stabilised liquid formulations of virus particles

Info

Publication number
GB201005521D0
GB201005521D0 GBGB1005521.8A GB201005521A GB201005521D0 GB 201005521 D0 GB201005521 D0 GB 201005521D0 GB 201005521 A GB201005521 A GB 201005521A GB 201005521 D0 GB201005521 D0 GB 201005521D0
Authority
GB
United Kingdom
Prior art keywords
liquid formulations
virus particles
stabilised liquid
stabilised
virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1005521.8A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Stabilitech Ltd
Original Assignee
Stabilitech Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stabilitech Ltd filed Critical Stabilitech Ltd
Priority to GBGB1005521.8A priority Critical patent/GB201005521D0/en
Publication of GB201005521D0 publication Critical patent/GB201005521D0/en
Priority to JP2013501930A priority patent/JP5869553B2/en
Priority to EP11714373.5A priority patent/EP2552465B1/en
Priority to EP15158279.8A priority patent/EP2898890B1/en
Priority to HUE11714594A priority patent/HUE033656T2/en
Priority to JP2013501933A priority patent/JP5960120B2/en
Priority to KR1020177022631A priority patent/KR101943429B1/en
Priority to CA2795013A priority patent/CA2795013C/en
Priority to ES11714594.6T priority patent/ES2617921T3/en
Priority to ES11714373.5T priority patent/ES2543795T3/en
Priority to PCT/GB2011/000498 priority patent/WO2011121306A1/en
Priority to ES15158279T priority patent/ES2757591T3/en
Priority to BR112012025047A priority patent/BR112012025047A2/en
Priority to GB1216473.7A priority patent/GB2490644A/en
Priority to CA2795047A priority patent/CA2795047C/en
Priority to AU2011234269A priority patent/AU2011234269B2/en
Priority to US13/637,817 priority patent/US10206960B2/en
Priority to CN201180018127.0A priority patent/CN102892424B/en
Priority to KR1020127028704A priority patent/KR101884953B1/en
Priority to CN2011800181285A priority patent/CN102892427A/en
Priority to HUE11714373A priority patent/HUE026885T2/en
Priority to DK11714594.6T priority patent/DK2552478T3/en
Priority to EP11714594.6A priority patent/EP2552478B1/en
Priority to PCT/GB2011/000493 priority patent/WO2011121301A1/en
Priority to GB1216469.5A priority patent/GB2499479A/en
Priority to DK11714373.5T priority patent/DK2552465T3/en
Priority to DK15158279T priority patent/DK2898890T3/en
Priority to HUE15158279A priority patent/HUE047521T2/en
Priority to US13/637,913 priority patent/US20130164296A1/en
Priority to AU2011234264A priority patent/AU2011234264B2/en
Priority to IL221857A priority patent/IL221857A/en
Priority to IL221858A priority patent/IL221858A/en
Priority to ZA2012/06956A priority patent/ZA201206956B/en
Priority to JP2016001536A priority patent/JP6053969B2/en
Priority to AU2016202839A priority patent/AU2016202839B2/en
Priority to US15/147,114 priority patent/US10716859B2/en
Priority to US16/237,889 priority patent/US20190307819A1/en
Ceased legal-status Critical Current

Links

GBGB1005521.8A 2010-03-31 2010-03-31 Stabilised liquid formulations of virus particles Ceased GB201005521D0 (en)

Priority Applications (37)

Application Number Priority Date Filing Date Title
GBGB1005521.8A GB201005521D0 (en) 2010-03-31 2010-03-31 Stabilised liquid formulations of virus particles
AU2011234264A AU2011234264B2 (en) 2010-03-31 2011-03-31 Excipients for stabilising viral particles, polypeptides or biological material
KR1020127028704A KR101884953B1 (en) 2010-03-31 2011-03-31 Excipients for Stabilising Viral Particles, Polypeptides or Biological Material
CN2011800181285A CN102892427A (en) 2010-03-31 2011-03-31 Excipients for stabilising viral particles, polypeptides or biological material
EP15158279.8A EP2898890B1 (en) 2010-03-31 2011-03-31 Stabilisation of viral particles
HUE11714594A HUE033656T2 (en) 2010-03-31 2011-03-31 Excipients for stabilising viral particles
JP2013501933A JP5960120B2 (en) 2010-03-31 2011-03-31 Stabilization of virus particles
DK11714594.6T DK2552478T3 (en) 2010-03-31 2011-03-31 EXCIPIENTS FOR STABILIZING VIRUS PARTICLES
CA2795013A CA2795013C (en) 2010-03-31 2011-03-31 Stabilisation of viral particles
ES11714594.6T ES2617921T3 (en) 2010-03-31 2011-03-31 Excipients to stabilize viral particles
ES11714373.5T ES2543795T3 (en) 2010-03-31 2011-03-31 Stabilization of viral particles
PCT/GB2011/000498 WO2011121306A1 (en) 2010-03-31 2011-03-31 Stabilisation of viral particles
ES15158279T ES2757591T3 (en) 2010-03-31 2011-03-31 Stabilization of viral particles
BR112012025047A BR112012025047A2 (en) 2010-03-31 2011-03-31 stabilized liquid formulations
GB1216473.7A GB2490644A (en) 2010-03-31 2011-03-31 Excipients for stabilising viral particles, polypeptides or biological material
CA2795047A CA2795047C (en) 2010-03-31 2011-03-31 Stabilised liquid formulations
AU2011234269A AU2011234269B2 (en) 2010-03-31 2011-03-31 Stabilisation of viral particles
US13/637,817 US10206960B2 (en) 2010-03-31 2011-03-31 Stabilisation of viral particles
CN201180018127.0A CN102892424B (en) 2010-03-31 2011-03-31 Stabilisation of viral particles
JP2013501930A JP5869553B2 (en) 2010-03-31 2011-03-31 Additives that stabilize virus particles, polypeptides or biomaterials
HUE11714373A HUE026885T2 (en) 2010-03-31 2011-03-31 Stabilisation of viral particles
EP11714373.5A EP2552465B1 (en) 2010-03-31 2011-03-31 Stabilisation of viral particles
KR1020177022631A KR101943429B1 (en) 2010-03-31 2011-03-31 Excipients for Stabilising Viral Particles, Polypeptides or Biological Material
EP11714594.6A EP2552478B1 (en) 2010-03-31 2011-03-31 Excipients for stabilising viral particles
PCT/GB2011/000493 WO2011121301A1 (en) 2010-03-31 2011-03-31 Excipients for stabilising viral particles, polypeptides or biological material
GB1216469.5A GB2499479A (en) 2010-03-31 2011-03-31 Stabilisation of viral particles
DK11714373.5T DK2552465T3 (en) 2010-03-31 2011-03-31 Stabilization of virus particles
DK15158279T DK2898890T3 (en) 2010-03-31 2011-03-31 Stabilization of virus particles
HUE15158279A HUE047521T2 (en) 2010-03-31 2011-03-31 Stabilisation of viral particles
US13/637,913 US20130164296A1 (en) 2010-03-31 2011-03-31 Excipients for Stabilising Viral Particles, Polypeptides or Biological Material
IL221858A IL221858A (en) 2010-03-31 2012-09-09 Stabilisation of viral particles
IL221857A IL221857A (en) 2010-03-31 2012-09-09 Stabilised liquid formulations
ZA2012/06956A ZA201206956B (en) 2010-03-31 2012-09-17 Excipients for stabilising viral particle, polypeptides or biological material
JP2016001536A JP6053969B2 (en) 2010-03-31 2016-01-07 Additives that stabilize virus particles, polypeptides or biomaterials
AU2016202839A AU2016202839B2 (en) 2010-03-31 2016-05-03 Excipients for stabilising viral particles, polypeptides or biological material
US15/147,114 US10716859B2 (en) 2010-03-31 2016-05-05 Excipients for stabilising viral particles, polypeptides or biological material
US16/237,889 US20190307819A1 (en) 2010-03-31 2019-01-02 Stabilisation of viral particles

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1005521.8A GB201005521D0 (en) 2010-03-31 2010-03-31 Stabilised liquid formulations of virus particles

Publications (1)

Publication Number Publication Date
GB201005521D0 true GB201005521D0 (en) 2010-05-19

Family

ID=42228755

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1005521.8A Ceased GB201005521D0 (en) 2010-03-31 2010-03-31 Stabilised liquid formulations of virus particles

Country Status (1)

Country Link
GB (1) GB201005521D0 (en)

Similar Documents

Publication Publication Date Title
IL221857A (en) Stabilised liquid formulations
IL221858A (en) Stabilisation of viral particles
ZA201301717B (en) Liquid agricultural formulations of improved stability
SG10201610753YA (en) Purification of virus like particles
SG11201405475UA (en) Pharmaceutical formulations of tnf-alpha antibodies
ZA201208336B (en) Controlled release pharmaceutical compositions of tapentadol
PL2585023T3 (en) Preparation of medical solutions from powdery material
PL2603232T3 (en) Stable formulations of linaclotide
GB2481881B (en) Liquid formulations
PL3438651T3 (en) Uses of marker substances
GB201104473D0 (en) Improved pharmaceutical compositions and methods of delivery
ZA201504408B (en) Solution formulations of engineered anti-il-23p19 antibodies
EP2646051A4 (en) Liquid viral formulations
IL229238A (en) Pharmaceutical composition of rosuvastatin calcium
PL2407155T3 (en) Formulations of inecalcitol
ZA201402165B (en) Compositions of lopinavir
EP2536688A4 (en) Stable dosage forms of levomilnacipran
GB201005521D0 (en) Stabilised liquid formulations of virus particles
PL2407159T3 (en) Pharmaceutical compositions of olmesartan
GB201407689D0 (en) Pharmaceutical compositions of antihypertensives
GB201017648D0 (en) Liquid preparation containing stabilised viruses
GB201005517D0 (en) Stabilised liquid formulations of polypeptides
GB201005520D0 (en) Stabilisation of viral particles
GB201003332D0 (en) Efficient preparation of combination vaccines
AU2011905465A0 (en) Wildthang mix of milk powder and muesli that takes it to the next level

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)